NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab ...

REUP avoids the ethical issues and costs of other procurement and recovery methods. So far, outcomes are excellent.

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

Linda Gillam and Cynthia Taub discuss how the latest ASE guidelines are redefining the role of echocardiographers, ...

Just 7% of HFrEF patients received quadruple therapy, and even in this group, the absolute risk of events at 1 year was high.

Clinicians who use the tool more often are less likely to order diagnostic tests and GDMT, even for HFrEF patients.

With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.

Michael Mack and Michael Borger outline the most important shifts and clarifications in the 2025 ESC/EACTS VHD guidelines.

Brian Lindman and Christopher Cook review the paradigm shift from passive watchful waiting to proactive management of severe ...

Taking into account estimated 30-year risk of atherosclerotic cardiovascular disease (ASCVD) enables clinicians to identify ...